AMPAKINE enhancement of social interaction in the BTBR mouse model of autism - Wikidata - awgldk - TriplyDB

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

http://www.wikidata.org/entity/Q28388762

about

Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain Behavioral phenotypes of genetic mouse models of autism.Modeling psychiatric disorders for developing effective treatments Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism Letting a typical mouse judge whether mouse social interactions are atypical Prosocial effects of oxytocin in two mouse models of autism spectrum disorders Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T+tf/J mouse model for autism.GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism.Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism.AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T⁺ tf/J mouse model of autism AMPA receptor potentiators: from drug design to cognitive enhancement Cognitive abilities on transitive inference using a novel touchscreen technology for mice.Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior.Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder.Potential therapeutic approaches for Angelman syndrome.Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena.Are AMPA receptor positive allosteric modulators potential pharmacotherapeutics for addiction?Role of stoichiometry in the dimer-stabilizing effect of AMPA receptor allosteric modulators.Progress toward treatments for synaptic defects in autism.A blueprint for research on Shankopathies: a view from research on autism spectrum disorder.Using genetic findings in autism for the development of new pharmaceutical compounds.New experimental treatments for core social domain in autism spectrum disorders.AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications.The BTBR mouse model of idiopathic autism - Current view on mechanisms.Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice.AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain.Brain Vacuolation Resulting from Administration of the Type II Ampakine CX717 is an Artifact Related to Molecular Structure and Chemical Reaction with Tissue Fixative Agents.Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.Rigor and Reproducibility in Rodent Behavioral Research.Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice.Pharmacological Modulation of AMPAR Rescues Intellectual Disability-Like Phenotype in Tm4sf2-/y Mice.Animal models for autism in 2017 and the consequential implications to drug discovery.AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.

P2860

Q21129314-5620F10C-5A35-4EB8-AD02-FAAEA537F482 Q26781456-FC706E54-6966-4BB7-B557-E1F88EED289C Q26784269-6913E008-1535-40A0-990D-646BE9C81459 Q28383216-2E586E89-A0D4-4A2C-973D-194340846D60 Q28383456-F981E8BF-62D7-4C23-9F69-CACF889E70F3 Q28386367-6AB13A85-1191-4ECE-8603-9DD28F995D03 Q28390065-72E08DF9-D2BA-4D6D-A4A5-D257ED46A256 Q28391720-21E2D87F-6F31-49DF-BA59-9C7D57F86166 Q28394524-CAF8E321-D639-4058-B4C4-4AB17D5F1B84 Q30438962-CFD7AB94-8B3D-4186-A04E-2F0E8E640523 Q33620574-80BBA7CD-AFDA-432E-9BBD-8D4CA07C77DA Q33805524-3501AD89-056C-4134-A81D-049971EC3A6A Q34390309-BB3825D2-854B-4D7E-B7FC-CF99A56E48A2 Q34685202-5792697C-0B34-4B2E-AA25-3D5586F13480 Q35054673-EAD1EB49-3124-47EC-8CB1-4B84104D1DFA Q35555297-B608C7E1-9964-4373-942B-6893BABF4D52 Q35899043-D6269A69-4B63-4831-9A62-5DF9C3619259 Q36011376-5E173270-67D1-46E4-9445-3DEEBA5E2E7A Q36992786-E3D84642-5DCA-44F7-9DCD-E1111C7FEE96 Q37134043-34606AEF-71BF-4B4E-B629-783F24341AB3 Q37307216-636CA1F2-02FD-496D-8187-1599241C4004 Q37321774-76F16923-5F04-468C-96A4-1D419C51ADF8 Q37559271-AB058926-2630-445F-94E1-FFD95A2D5B06 Q37625512-4B3DA567-0AE6-494D-90EC-C626DD9CBE15 Q38112617-CB87E1CC-E0B2-44D2-B099-34E10BDF0E3E Q38161847-519024A9-D272-47DB-A0F1-4686C97F1D09 Q38167615-E1223542-365E-4F64-89FE-3E70B7957417 Q38226820-63520EA7-AE23-4967-9067-AE83633D69E9 Q38421802-55D92578-8B42-424F-A5E1-AAA5A6E21856 Q38975802-F7BBF165-CABC-48E9-ACC9-93DBDD2B59D8 Q38976018-88396580-AF96-46C4-9497-FAA3BF72F60A Q42990805-CE479B6F-8383-4DDE-9C4E-98F614369766 Q46237503-CF2B5F30-1408-4304-8CFB-3402EFD2762D Q46326120-DC731216-7860-40E1-ADE1-238745C51F34 Q47200848-13092E02-0F10-47A7-86BF-3E0D4267292F Q47202360-11BC5E9B-957F-483A-86F7-B36EED9F6C4C Q47582921-0E986C1F-4DBE-44BD-B019-C7DE20D0F9C8 Q47610094-CBA78FFC-245F-4B7E-B171-BEDB34EF6D82 Q47668964-EAC99162-4F89-471E-B470-96B947675C65 Q47902006-A4BC4A3D-05F3-46D5-89B8-B8736C89858F

P2860

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

http://www.wikidata.org/entity/Q28388762

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@ast

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@en

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@nl

type

label

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@ast

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@en

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@nl

prefLabel

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@ast

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@en

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@nl

P1433

Q28388762-5EFE176C-30D3-404E-9D06-FEEC8C9E034F

P1476

Q28388762-1737803A-E92E-415E-98FE-338EE3625B86

P2093

Q28388762-02A4093D-7D41-456E-BFBA-B8450EEC1914

Q28388762-0BD38B3A-C921-40C2-B8C0-21302BE97399

Q28388762-7A7C6F0E-1F4E-4AA2-8CA4-0EBEBA9C138E

Q28388762-ADEFC35E-9743-48C4-BE56-9BF3D6479115

Q28388762-C61D9DB4-48A5-4E34-9541-AF754A00F459

P2860

Q28388762-02BABC34-0A93-45EE-A3A5-CA1C7C6C1988

Q28388762-05F8C918-A075-44F0-B170-32121B4B988D

Q28388762-09CB90CA-D936-4668-8CBB-AEBDD2E33101

Q28388762-0B20B542-A4A1-4D7F-856E-1DE24538948C

Q28388762-0B965276-3E3F-41B9-B141-2EC40A2DF674

Q28388762-0BD83074-FCCD-413F-B5C4-39CD2300D42D

Q28388762-1052F7DF-1000-4CA8-964D-01F5CE80DB8F

Q28388762-15DA8B36-8078-4698-906B-AD2928C4068A

Q28388762-1779256F-2241-43DA-B439-7F72DFBB401E

Q28388762-1A25421B-12BB-410A-BC4F-70BDDC65BF38

P304

Q28388762-D9F4E613-BD09-45B3-B86F-6BF15A6FFDD2

P31

Q28388762-BC416BB9-0F70-499B-A4A5-584436EFCE01

P3181

Q28388762-054531CE-0D14-4621-A1EE-A6323519E404

P356

Q28388762-12C39F41-B401-42A2-9D54-40B5731B84F6

P407

Q28388762-36B40AC1-D6A5-4740-99E3-8BE2FA48A14E

P478

Q28388762-C045C686-C335-47B5-8CF1-F85EEC21D193

P577

Q28388762-103B1C36-A210-4F7A-98C7-AF0A818199E9

P698

Q28388762-38255DC3-C59D-43A7-BAB3-78B7510F2876

P921

Q28388762-2DBFF32E-44D2-4521-BC3F-C0FCCBE926FB

P932

Q28388762-F484BAF1-3C94-4A18-94CA-60A82247962F

P3181

P356

J.NEUROPHARM.2012.07.013

P1433

Neuropharmacology

P1476

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

@en

P2093

C F Oliver

http://www.w3.org/2001/XMLSchema#string

J L Silverman

http://www.w3.org/2001/XMLSchema#string

J N Crawley

http://www.w3.org/2001/XMLSchema#string

M N Karras

http://www.w3.org/2001/XMLSchema#string

P T Gastrell

http://www.w3.org/2001/XMLSchema#string

P2860

Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.

Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition

Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication

Autism and autism spectrum disorders: diagnostic issues for the coming decade

Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter

Attention-modulating effects of cognitive enhancers

Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity.

Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression

An analysis of calendar performance in two autistic calendar savants

P304

268-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3324369

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEUROPHARM.2012.07.013

http://www.w3.org/2001/XMLSchema#string

P407

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22801296

http://www.w3.org/2001/XMLSchema#string

P921

P932

3445667

http://www.w3.org/2001/XMLSchema#string